Maelstrom Research Staging | SCQM_PsA

SCQM_PsA_Baseline

Networks -

Variables -

Associated study SCQM Contingency Table

Population

SCQM - PsA

The population is composed of all patients with psoriatic arthritis (PsA) diagnosed by the treating rheumatologist.

Selection Criteria

Newborns

Twins

Countries

Switzerland

Ethnic Origin

Health Status

Clinical diagnosis or suspicion of psoriatic arthritis

Other Criteria

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Participants are included in the registry by the treating rheumatologist. More than 65% of the rheumatologists, who contributed data on PsA patients, were from private practices. The inclusion of the rheumatologist and the patients in the study is voluntary.

Number of Participants

Number of Participants: 2,892
Number of Participants with Biological Samples

More info

Data Collection Event

SCQM - PsA - Baseline

Information about demographics, disease characteristics, concomitant treatments, comorbidities and adverse events was collected. Self-administered questionnaires such as Health Assessment Questionnaire, Dermatology Life Quality Index, 12-Item Short Form Survey and health-related quality of life measurement instruments (EuroQoL) were completed. Hand, foot, spine and sacroiliac joint X-Rays were performed every 2-3 years at the discretion of the treating physician. Biosample(s) timing is left at the discretion of the treating physician. As a first aim of the biobank, at least one sample for each patient should be collected.

More info

Collected Dataset / SCQM_PsA_Baseline

SCQM_PsA_Baseline

Population

SCQM - PsA

Data Collection Event

SCQM - PsA - Baseline

Files

Variables Classifications